PHARMACOKINETICS OF EXCRETION OF 5-AZACYTIDINE (NSC 102816) AND ITS METABOLITES

被引：0
|
作者：
COLES, E [1 ]
THAYER, PS [1 ]
REINHOLD, V [1 ]
GAUDIO, L [1 ]
机构：
[1] ARTHUR D LITTLE INC,CAMBRIDGE,MA 02140
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1974年 / 15卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] ABSORPTION, DISTRIBUTION, AND EXCRETION OF 5-AZACYTIDINE (NSC-102816) IN MAN
    TROETEL, WM
    STAMBAUGH, JE
    WEISS, AJ
    LAUCIUS, JF
    MANTHEI, RW
    CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (03): : 405 - +
  • [2] TREATMENT OF ACUTE LEUKEMIA WITH 5-AZACYTIDINE (NSC-102816)
    MCCREDIE, KB
    BODEY, GP
    BURGESS, MA
    GUTTERMAN, JU
    RODRIGUEZ, V
    SULLIVAN, MP
    FREIREICH, EJ
    CANCER CHEMOTHERAPY REPORTS PART 1, 1973, 57 (03): : 319 - 323
  • [3] PHASE I STUDY OF 5-AZACYTIDINE (NSC-102816)
    SHNIDER, BI
    BAIG, M
    COLSKY, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (04): : 205 - 212
  • [4] PHASE I STUDY OF 5-AZACYTIDINE (NSC-102816)
    WEISS, AJ
    STAMBAUGH, JE
    MASTRANGELO, MJ
    LAUCIUS, JF
    BELLET, RE
    CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (03): : 413 - +
  • [5] CLINICAL TRIAL WITH SUBCUTANEOUSLY ADMINISTERED 5-AZACYTIDINE (NSC-102816)
    BELLET, RE
    MASTRANGELO, MJ
    ENGSTROM, PF
    STRAWITZ, JG
    WEISS, AJ
    YARBRO, JW
    CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (02): : 217 - 222
  • [6] 5-AZACYTIDINE (NSC 102816) - NEW DRUG FOR TREATMENT OF MYELOBLASTIC LEUKEMIA
    VOGLER, WR
    MILLER, DS
    KELLER, JW
    BLOOD, 1976, 48 (03) : 331 - 337
  • [7] HEPATOTOXICITY OF 5-AZACYTIDINE (NSC-102816) (A CLINICAL AND PATHOLOGIC-STUDY)
    BELLET, RE
    MASTRANGELO, MJ
    ENGSTROM, PF
    CUSTER, RP
    NEOPLASMA, 1973, 20 (03) : 303 - 309
  • [8] ANTI-TUMOR ACTIVITY OF PYRAZOFURIN (NSC 143095) IN COMBINATION WITH 5-AZACYTIDINE (NSC 102816) IN MICE
    CHIUTEN, DF
    JOHNSON, RK
    MUGGIA, FM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 230 - 230
  • [9] EFFECTS OF DRUG COMBINATIONS ON METABOLISM AND EXCRETION OF 5-AZACYTIDINE (5-AZACR, NSC 102816) IN BDF1 MICE
    COLES, E
    WODINSKY, I
    GAUDIO, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 91 - 91
  • [10] PHASE-I STUDY USING COMBINATION OF HYDROXYUREA AND 5-AZACYTIDINE (NSC 102816)
    LOMEN, PL
    KHILANANI, P
    KESSEL, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 313 - 313
12345